Philippe Rougier

Medicine · Health Sciences

44h-index10.8kcitations172works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(59), Hepatocellular Carcinoma Treatment and Prognosis(38), Gastric Cancer Management and Outcomes(33), Cancer Treatment and Pharmacology(23), Colorectal and Anal Carcinomas(20)

Publications171 total

Hepatic arterial infusion in the management of colorectal cancer liver metastasis: Current and future perspectives
Digestive and Liver Disease·2017· 29 cited
Improving Outcomes in Patients with CRC: The Role of Patient Reported Outcomes—An ESDO Report
Cancers·2017· 8 citedOpen Access
Hepatic Arterial Infusion Chemotherapy for Unresectable Liver Metastases of Colorectal Cancer: A Multicenter Retrospective Study
Clinical Colorectal Cancer·2017· 30 cited
Treatment sequence of synchronously (liver) metastasized colon cancer
Digestive and Liver Disease·2016· 15 cited
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983)
2016· 2 cited
Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV
Annals of Oncology·2015· 140 cited
Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001–02)
Annals of Oncology·2015· 104 citedOpen Access
Radiochemotherapy Versus Surgery in Nonmetastatic Anorectal Neuroendocrine Carcinoma
Medicine·2015· 29 citedOpen Access
Irinotecan drug eluted beads as a closure treatment for controlled liver colorectal cancer metastases after more than 2 systemic chemotherapy regiments
Journal of Vascular and Interventional Radiology·2014
Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis
JNCI Journal of the National Cancer Institute·2013· 89 citedOpen Access
Iconography : Digestive neuroendocrine tumors (DNET): The era of targeted therapies
2013
Role of chemotherapy for advanced/recurrent gastric cancer: An individual-patient-data meta-analysis
European Journal of Cancer·2013· 161 cited
Implication des hépato-gastroentérologues en cancérologie digestive ? Enquête de la Fédération des spécialités des maladies de l’appareil digestif (FSMAD) et la Fédération francophone de cancérologie digestive (FFCD)
2012· 1 cited
EORTC liver metastases intergroup randomized phase III study 40983: Long-term survival results.
Journal of Clinical Oncology·2012· 38 cited
Iconography : An unusual recurrence site for HCC!
2012
Prolonged Complete Response after GEMOX Chemotherapy in a Patient with Advanced Fibrolamellar Hepatocellular Carcinoma
Case Reports in Oncology·2012· 53 citedOpen Access
膵臓腺癌: 診断と治療と追跡のためのESMO-ESDO臨床診療指針
Annals of Oncology·2012
Identification of molecular pathways involved in oxaliplatin-associated sinusoidal dilatation
Journal of Hepatology·2011· 51 cited
Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy
Clinical Cancer Research·2011· 78 cited
Topoisomerase I Inhibitors: Current Use and Prospects
Cancer drug discovery and develogment/Cancer drug discovery and development·2011· 2 cited
page 1 of 9Next →

Frequent Co-authors

Michel Ducreux(13), Laurent Bedenne(10), Olivier Bouché(9), Franck Bonnetain(8), Eric Van Cutsem(6), Bernard Nordlinger(6), R. Bugat(5), Jean‐Luc Raoul(5), Jean‐Pierre Droz(5), F. Masskouri(5), Jean‐François Seitz(4), Harry Bleiberg(4), Dominique Elias(4), Jean‐Pierre Pignon(4), Xavier Paolettí(4), Jean‐Claude Barbare(4), Julien Taı̈eb(4), Aimery de Gramont(3), Christophe Louvet(3), Jean‐Pierre Armand(3)